PBT surged on a 25.6% revenue lift driven by prior-year acquisition

Management's own commentary cites a 10% increase in operating revenue to NZ$26.3m and an underlying EBITDAF of NZ$3.8m (down 8% year-on-year), which tells a materially different story than the headline statutory revenue figure.

PBT rose substantially from NZ$0.5m to NZ$3.6m — a large move in absolute terms from a low base, though the percentage gain is not cited here due to its implausibly large magnitude as a reliable growth metric. NPAT grew 128.6% to NZ$1.6m, lifted partly by a negative effective tax rate of -54.6% versus -49.5% in the prior year, which inflates statutory net profit above the underlying operating read.

Operating cash flow improved modestly to NZ$7.5m from NZ$7.1m. Gross borrowings fell 5.6% to NZ$29.2m while total assets expanded 17.5% to NZ$84.3m, reflecting the balance-sheet growth from the prior acquisition cycle. Cash on hand fell sharply from NZ$2.1m to NZ$0.1m.

Management's preferred measure — operating revenue of NZ$26.3m, up 10% — is the more meaningful growth reference. The underlying EBITDAF of NZ$3.8m, down 8%, signals that earnings power did not keep pace with the expanded revenue base, so the acquisition has yet to deliver margin accretion.

The negative effective tax rate materially distorts NPAT as an operating measure. At -54.6%, the current tax rate implies a deferred tax benefit of significant size relative to the NZ$3.6m PBT. This means NPAT of NZ$1.6m overstates economic profitability; PBT is the cleaner earnings read, and even that figure benefits from a low prior-year base.

The cash position is now effectively depleted. Cash fell from NZ$2.1m to NZ$0.1m despite operating cash flow of NZ$7.5m, because debt service and investing activity consumed most of the operating inflows. With net debt at approximately NZ$29.0m and no disclosed undrawn-facility detail in the financials beyond management's reference to undrawn capacity, the headroom for capital allocation or further growth is constrained.

Management's commentary emphasises second-half momentum, and the half-year shape supports this: first-half NPAT was a NZ$0.2m loss, meaning the NZ$1.8m implied second-half NPAT carried essentially all of the annual profit. The 10% operating revenue growth and declining underlying EBITDAF suggest the business is still embedding the acquisition and working through cost-base management, rather than demonstrating operational leverage.

The stated strategy centres on occupancy improvement, revenue diversification, and network growth — but no FY25 targets are given. Whether the second-half momentum can be sustained, and whether the underlying EBITDAF can return toward its prior-year level, are the key unresolved forward questions this release does not answer.

This means FCF improved sharply not because the business generated more earnings, but because the investment cycle wound down. That improvement should not be extrapolated as a new run rate unless management confirms the capital programme has genuinely been normalised.

NPAT quality is further weakened by the deferred tax benefit embedded in the -54.6% effective tax rate. PBT of NZ$3.6m is the more transparent earnings measure, but even that figure arises from a very low FY23 base of NZ$0.5m. The underlying EBITDAF of NZ$3.8m, cited by management but not reconciled in the preliminary financials, was actually down 8% year-on-year — so reported earnings improvement and underlying operating improvement are moving in opposite directions.

This briefing cannot assess the recoverability of the deferred tax asset, the sustainability of second-half occupancy rates, or the terms of the debt facilities that underpin the company's financial flexibility.